Trials / Recruiting
RecruitingNCT06830551
The Effect of Cord Blood Serum Eyes Drops Administer in Patients With Severe Keratopathy Related to EGFR-I Treatment
Personalized Approach in the Treatment of Patients Affected by Severe Dry Eye Associated With Therapy With EGFR Inhibitors (EGRFR-I) With Growth Factors in Cord Blood Serum (CBS) Eye Drops
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aim to evaluate the efficacy of cord blood eye drops in the healing of the damaged corneal epithelium.
Detailed description
Patients undergoing treatment with EGFR inhibitor for lung cancer might develop corneal damage. The study aims to evaluate the healing of corneal epithelium by administering cord blood eye drops for one month.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | administration cord blood based eye drops, standardized to the deliver BDNF. | administration cord blood based eye drops customized to deliver epitelio tropic factors, incluiding EGF in EGFR blocked cells |
Timeline
- Start date
- 2023-09-12
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2025-02-17
- Last updated
- 2025-02-17
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06830551. Inclusion in this directory is not an endorsement.